WMT

95.29

-0.26%↓

COST

970.95

-0.32%↓

KR

69.95

-2.79%↓

TGT

95.55

+1.53%↑

STZ

185.41

-0.3%↓

WMT

95.29

-0.26%↓

COST

970.95

-0.32%↓

KR

69.95

-2.79%↓

TGT

95.55

+1.53%↑

STZ

185.41

-0.3%↓

WMT

95.29

-0.26%↓

COST

970.95

-0.32%↓

KR

69.95

-2.79%↓

TGT

95.55

+1.53%↑

STZ

185.41

-0.3%↓

WMT

95.29

-0.26%↓

COST

970.95

-0.32%↓

KR

69.95

-2.79%↓

TGT

95.55

+1.53%↑

STZ

185.41

-0.3%↓

WMT

95.29

-0.26%↓

COST

970.95

-0.32%↓

KR

69.95

-2.79%↓

TGT

95.55

+1.53%↑

STZ

185.41

-0.3%↓

Search

Hims & Hers Health Inc

Abierto

SectorConsumo defensivo

27.51 -1.4

Resumen

Variación precio

24h

Actual

Mínimo

27.01

Máximo

28.73

Métricas clave

By Trading Economics

Ingresos

-50M

26M

Ventas

80M

481M

P/B

Media del Sector

48.755

40.769

BPA

0.227

Margen de beneficios

5.409

Empleados

1,637

EBITDA

-8.2M

19M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+71.36% upside

Dividendos

By Dow Jones

Próximas Ganancias

5 may 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-5.2B

6B

Apertura anterior

28.91

Cierre anterior

27.51

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Hims & Hers Health Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

4 abr 2025, 22:38 UTC

Acciones populares

Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies

1 abr 2025, 23:15 UTC

Principales Movimientos del Mercado

Hims & Hers Adds Eli Lilly's Zepbound in Expansion of Weight-Loss Offerings -- 2nd Update

25 feb 2025, 15:33 UTC

Principales Movimientos del Mercado

Novo Nordisk Shares Rise as Hims & Hers to Stop Mimicking Weight-Loss Drugs

18 nov 2024, 19:07 UTC

Principales Movimientos del Mercado

Hims & Hers Stock Climbs After Former Regulator Autor Joins Board

14 oct 2024, 15:02 UTC

Principales Movimientos del Mercado

Hims & Hers Health Shares Jump After FDA Set to Reconsider Limits on Knockoff Weight-Loss Drugs

3 oct 2024, 11:28 UTC

Principales Movimientos del Mercado

Hims & Hers Health Shares Fall After FDA Removes Eli Lilly Obesity Drugs From Shortage List

2 abr 2025, 16:53 UTC

Principales Noticias

Hims & Hers Zepbound Offering Won't Bring Needed Sales Boom -- Analysis

19 mar 2025, 15:54 UTC

Principales Noticias

Sale of Ozempic Knockoffs Are Supposed to End Soon. Telehealth Companies Aren't Happy. -- WSJ

21 feb 2025, 23:20 UTC

Ganancias

These Stocks Moved the Most Today: UnitedHealth, Alibaba, Rivian, Celsius, Booking, Block, Akamai, Hims & Hers, and More -- Barrons.com

10 feb 2025, 12:00 UTC

Principales Noticias

Hims Super Bowl Ad Spotlights Weight-Loss Drug Copycats as Clock Ticks on Their Business -- Heard on the Street -- WSJ

19 dic 2024, 17:16 UTC

Principales Noticias

FDA Says Shortage of Eli Lilly's Zepbound is Over, But Gives Compounders a Grace Period -- Barrons.com

19 dic 2024, 15:14 UTC

Principales Noticias

Eli Lilly's Zepbound Shortage Is Officially Over, FDA Says -- Barrons.com

19 dic 2024, 15:02 UTC

Principales Noticias

The Zepbound Shortage Is Officially Over, FDA Says -- Barrons.com

16 dic 2024, 13:47 UTC

Principales Noticias

The Weight-Loss Drug Market Is Heading for a Reckoning This Week -- Barrons.com

16 dic 2024, 07:00 UTC

Principales Noticias

The Weight-Loss Drug Market Is Heading for a Reckoning This Week. What to Expect. -- Barrons.com

3 oct 2024, 14:45 UTC

Principales Noticias

Eli Lilly's Weight-Loss Drugs Are No Longer in Short Supply. Bad News for Hims & Hers. -- Barrons.com

3 oct 2024, 13:12 UTC

Principales Noticias

Eli Lilly's Weight-Loss Drugs No Longer in Shortage. Bad News for Hims & Hers. -- Barrons.com

3 oct 2024, 11:45 UTC

Principales Noticias

Update: Eli Lilly's Weight-Loss Drugs No Longer in Shortage. Bad News for Hims & Hers. -- Barrons.com

3 oct 2024, 10:14 UTC

Principales Noticias

Update: Eli Lilly's Weight-Loss Drugs No Longer In Shortage. It's Bad News for These Stocks. -- Barrons.com

2 ago 2024, 17:52 UTC

Adquisiciones, fusiones, absorciones

Hims & Hers Plan to Sell Knockoff Weight Loss Drug Looking Shaky -- Barrons.com

26 jun 2024, 11:00 UTC

Principales Noticias
Adquisiciones, fusiones, absorciones

The War Over Cheaper Ozempic Won't End Well for Some Investors -- Heard on the Street -- WSJ

24 may 2024, 20:37 UTC

Ganancias

The Score: Target, Nvidia, Live Nation and More Stocks That Defined the Week -- WSJ

Comparación entre iguales

Cambio de precio

Hims & Hers Health Inc previsión

Precio Objetivo

By TipRanks

71.36% repunte

Estimación a 12 Meses

Media 45.77 USD  71.36%

Máximo 85 USD

Mínimo 22 USD

De acuerdo con 13 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Hims & Hers Health Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

13 ratings

5

Comprar

6

Mantener

2

Vender

Puntuación técnica

By Trading Central

27.2 / 29Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Bullish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Hims & Hers Health Inc

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.